United States· US:0143-9596_5830f342-11e2-4859-98c8-fdcfd89d606d

Paricalcitol

A paricalcitol product containing paricalcitol, registered in United States by West-Ward Pharmaceuticals Corp. The same ATC class is registered in 12 of our 19 countries.

ATC H05BX02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedParicalcitolATCH05BX02REGISTER NO.US:0143-9596_5830f342…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Paricalcitol is registered in 12 of 19 countries.

Countries holding a registration under ATC H05BX02 (paricalcitol), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Paricalcitol · ATC H05BX02

12 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paricalcitol costs, country by country.

Normalised to the WHO defined daily dose (2 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paricalcitol · price per daily dose (2 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$11.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PARICALCITOL
Manufacturer
West-Ward Pharmaceuticals Corp
Country
United States (US)
ATC code
H05BX02
ATC class
Paricalcitol
Defined daily dose
2 mcg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0143959625
    25 VIAL, MULTI-DOSE in 1 CARTON (0143-9596-25) / 2 mL in 1 VIAL, MULTI-DOSE (0143-9596-01)
  • ndc11
    0143-9596-25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

285 interactions on record for paricalcitol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paricalcitol · interactions on record

285 records

  • 11 severe
  • 108 moderate
  • 166 info

Most severe, free to view

  • SucralfateA02BX02severe
  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paricalcitol in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paricalcitol products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Paricalcitol Accord, Zemplar
  • Bulgaria · Тевапаривит
  • Cyprus · Rextol
  • Czechia · Paricalcitol Accord, Paricalcitol Agmed
  • Germany · Paricalcitol Accord, Paricalcitol Hexal
  • Denmark · Paricalcitol Pharmathen
  • Spain · Paricalcitol Accord, Paricalcitol Accordpharma
  • Finland · Paricalcitol Accord, Paricalcitol Alternova
  • United Kingdom (Northern Ireland) · Zemplar
  • Greece · Aricitol, Panozin
  • Croatia · Parkol, Zemplar
  • Hungary · Paricalcitol Fresenius, Paricalcitol Onkogen
  • Ireland · Paricalcitol Pinewood Laboratories, Zemplar
  • Italy · Paracalcitolo Mylan, Paracalcitolo Sandoz
  • Luxembourg · Porontazin
  • Netherlands · Paricalcitol Accord, Paricalcitol Heaton
  • Norway · Paricalcitol Alternova
  • Poland · Paricalcitol Fresenius
  • Portugal · Paricalcitol Accord, Paricalcitol Altan
  • Romania · Paricalcitol, Rextol
  • Sweden · Paricalcitol Accord, Paricalcitol Alternova
  • Slovenia · Zemplar
  • Slovakia · Paricalcitol Heaton, Zemplar

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1bcda2f-b26f-4dd7-9bfb-4b4ea1c632e7
GET /v1/drugs/c1bcda2f-b26f-4dd7-9bfb-4b4ea1c632e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "5",
  "substance": "PARICALCITOL",
  "productndc": "0143-9596",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "ug/mL",
  "application_number": "NDA205917",
  "marketing_category": "NDA"
}

See everything about paricalcitol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.